FIELD: medicine.
SUBSTANCE: invention represents a recovered nucleic acid with a nucleotide sequence coding human lysosomal glucocerebrosidase protein continuously bound with C-terminal vacuolar target signal and N-terminal signal peptide of endoplasmic reticulum. The invention concerns host-cells, vectors and methods for expression and production of high-yield biologically active glucocerebrosidase (GCD) with high mannose content. The invention also concerns pharmaceutical compositions and methods of treating Gaucher disease.
EFFECT: invention allows high-efficient treatment of Gaucher disease.
54 cl, 22 dwg, 3 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
PRODUCTION OF HIGH-MANNOSE PROTEINS IN PLANT CULTURES | 2009 |
|
RU2535342C2 |
PRODUCTION OF GLYCOPROTEINS WITH MODIFIED FUCOSYLATION | 2008 |
|
RU2479629C2 |
LYSOSOMAL DISEASE ACCUMULATION ENZYME | 2017 |
|
RU2741116C2 |
METHOD FOR PURIFICATION OF IMIGLUCERASE | 2017 |
|
RU2668158C1 |
LYSOSOMAL STORAGE DISORDER ENZYME | 2011 |
|
RU2575074C2 |
MEDICINE ON BASIS OF BIFUNCTIONAL ANTIBODY FOR TREATMENT OF II TYPE MUCOPOLYSACCHARIDOSIS | 2016 |
|
RU2673038C2 |
PRODUCTION OF ACTIVE HIGHLY PHOSPHORYLATED N-ACETYLGALACTOSAMINE-6-SULPHATASE AND USE THEREOF | 2011 |
|
RU2607376C2 |
DISPOSABLE APPARATUS FOR CULTURING AND COLLECTING PLANT TISSUE AND/OR CELLS, METHOD AND SYSTEM FOR CULTURING AND COLLECTING PLANT TISSUE AND/OR PLANT CELLS | 2008 |
|
RU2468076C2 |
PRODUCING ACTIVE HIGHLY PHOSPHORYLATED HUMAN LYSOSOMAL SULPHATASE ENZYMES AND USE THEREOF | 2009 |
|
RU2510820C2 |
METHODS AND MATERIALS FOR TREATMENT OF POMPE DISEASE | 2013 |
|
RU2644258C2 |
Authors
Dates
2010-04-10—Published
2004-02-24—Filed